From The Helm | Interview with CEO Dr Howie McKibbon

/in , , , /by

While in Australia last month, Botanix CEO Dr Howie McKibbon spoke with Bell Direct’s Grady Wulff about the Company’s FDA-approved product, Sofdra™, the competitive landscape in dermatology, and the outlook for Botanix over the next 12 months. 

Take a look: